Promising Strategy For Building New Drugs

  • Author:
  • Published: 10 August 2018
  • Copyright: Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
  • Source / Publisher: Nature/Nature Publishing Group
thumbnail image: Promising Strategy For Building New Drugs

Phil Baran and colleagues, The Scripps Research Institute (TSRI), La Jolla, CA, USA, USA, have developed a strategy for synthesizing molecular skeletons of chemicals used in drugs and other important products. The method combines C–C cross-coupling and cycloaddition. C–C cross-coupling, the method of choice in the pharmaceutical industry for synthesizing the skeletons of drug candidates, is limited in its ability to construct complex three-dimensional architectures. Cycloaddition reactions allow building highly complex 3D shapes in a single step. However, highly customized preparation often limits their use. This has led to a disproportionate representation of flat architectures that are rich in carbon atoms with orbitals hybridized in an sp2 manner.

The team combined the optimal features of these two chemical transformations into one simple sequence. This allows the modular, enantioselective, scalable, and programmable preparation of useful building blocks, natural products, and lead scaffolds for drug discovery. The new strategy overcomes a number of hurdles to synthesize molecules in a stepwise fashion, beginning by building a molecular scaffold using cycloaddition, setting its 3D shape, and then use of C–C cross-coupling to connect other molecular entities to the cycloaddition-built scaffold.

The team tested their method by constructing more than 80 examples of complex molecules, including natural products such as epibatidine and compounds currently produced at industrial scale but with different methods. In many cases, the technique offered advantages in terms of fewer steps, greater yield, and the ability to produce a wider variety of forms of certain molecules.

According to the researchers, their method allows to simply and efficiently build a wide variety of molecular architectures. This could speed the discovery of new drugs and the synthesis of natural products.


Also of Interest

Article Views: 3330

Sign in Area

Please sign in below

Additional Sign In options

Please note that to comment on an article you must be registered and logged in.
Registration is for free, you may already be registered to receive, e.g., the newsletter. When you register on this website, please ensure you view our terms and conditions. All comments are subject to moderation.

Article Comments - To add a comment please sign in

Bookmark and Share

If you would like to reuse any content, in print or online, from, please contact us first for permission. more

CONNECT: on Facebook on Twitter on YouTube on LinkedIn Sign up for our free newsletter

A product of ChemPubSoc Europe (16 European Chemical Societies)and Wiley-VCH